Translation from cryptic reading frames of DNA vaccines generates an extended repertoire of immunogenic, MHC class I-restricted epitopes

Journal of Immunology

Volumn 174, Issue 8, 2005, Pages 4647-4656

  Schirmbeck, Reinhold ^a   Riedl, Petra ^a   Fissolo, Nicolas ^a   Lemonnier, Francois A ^b   Bertoletti, Antonio ^c   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; DNA DIRECTED DNA POLYMERASE ALPHA; DNA VACCINE; EPITOPE; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS ANTIGEN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMICAL ANALYSIS; CONTROLLED STUDY; FEMALE; HEPATITIS B; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; TRANSCRIPTION INITIATION;

EID: 17044440337     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.8.4647     Document Type: Article

References (34)

1. Boon, T., and A. van Pel. 1989. T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions: a hypothesis. Immunogenetics 29:75.
2. Mayrand, S. M., and W. R. Green. 1998. Non-traditionally derived CTL epitopes: exceptions that prove the rules? Immunol. Today 19:551.
3. Shastri, N., S. Schwab, and T. Serwold. 2002. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20:463.
4. Shastri, N., and F. Gonzalez. 1993. Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells. J. Immunol. 150:2724.
5. Elliott, T., H. Bodmer, and A. Townsend. 1996. Recognition of out-of-frame major histocompatibility complex class I-restricted epitopes in vivo. Eur. J. Immunol. 26:1175.
6. Bullock, T. N., A. E. Patterson, L. L. Franlin, E. Notidis, and L. C. Eisenlohr. 1997. Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression. J. Exp. Med. 186:1051.
7. Robbins, P. F., M. El Gamil, Y. F. Li, E. B. Fitzgerald, Y. Kawakami, and S. A. Rosenberg. 1997. The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes. J. Immunol. 159:303.
8. Mayrand, S. M., D. A. Schwarz, and W. R. Green. 1998. An alternative translational reading frame encodes an immunodominant retroviral CTL determinant expressed by an immunodeficiency-causing retrovirus. J. Immunol. 160:39.
9. Schwab, S. R., K. C. Li, C. Kang, and N. Shastri. 2003. Constitutive display of cryptic translation products by MHC class I molecules. Science 301:1367.
10. Cardinaud, S., A. Moris, M. Fevrier, P. S. Rohrlich, L. Weiss, P. Langlade-Demoyen, F. A. Lemonnier, O. Schwartz, and A. Habel. 2004. Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames. J. Exp. Med. 199:1053.
11. Donnelly, J. J., J. B. Ulmer, J. W. Shiver, and M. A. Liu. 1997. DNA vaccines. Annu. Rev. Immunol. 15:617.
12. Gurunathan, S., D. M. Klinman, and R. A. Seder. 2000. DNA vaccines: immunology, application and optimization. Annu. Rev. Immunol. 18:927.
13. Schirmbeck, R., and J. Reimann. 2001. Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen. Biol. Chem. 382:543.
14. Wild, J., B. Grüner, K. Metzger, A. Kuhröber, H.-P. Pudollek, H. Hauser, R. Schirmbeck, and J. Reimann. 1998. Polyvalent vaccination against hepatitis B surface and core antigen using dicistronic expression plasmids. Vaccine 16:353.
15. Hennecke, M., M. Kwissa, K. Metzger, A. Oumard, A. Kröger, R. Schirmbeck, J. Reimann, and H. Hauser. 2001. Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs. Nucleic Acids Res. 29:3327.
16. Kwissa, M., J. Unsinger, R. Schirmbeck, H. Hauser, and J. Reimann. 2000. Polyvalent DNA vaccines with bidirectional promoters. J. Mol. Med. 78:495.
17. + T cell responses to epitopes of viral antigens produced from overlapping reading frames of a single coding sequence. Eur. J. Immunol. 35:117.
18. Galibert, F., E. Mandart, F. Fitoussi, P. Tiollais, and P. Charnay. 1979. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281:646.
19. Moolla, N., M. Kew, and P. Arbuthnot. 2002. Regulatory elements of hepatitis B virus transcription. J. Viral Hepat. 9:323.
20. Siddiqui, A., S. Jameel, and J. Mapoles. 1986. Transcriptional control elements of hepatitis B surface antigen gene. Proc. Natl. Acad. Sci. USA 83:566.
21. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. Melief, C. Oseroff, L. Yuan, and J. Ruppert. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586.
22. Rehermann, B., P. Fowler, J. Sidney, J. Person, A. Redeker, M. Brown, B. Moss. A. Sette, and F. V. Chisari. 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181:1047.
23. Rehermann, B., D. Lau, J. H. Hoofnagle, and F. V. Chisari. 1996. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J. Clin. Invest. 97:1655.
24. Loirat, D., F. A. Lemonnier, and M.-L. Michel. 2000. Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization. J. Immunol. 165:4748.
25. Zu Putlitz, J., J. Encke, and J. R. Wands. 2000. Cytotoxic T cell responses against hepatitis B virus polymerase induced by genetic immunization. J. Hepatol. 33:986.
26. Kakimi, K., M. Isogawa, J. Chung, A. Sette, and F. V. Chisari. 2002. Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections. J. Virol. 76:8609.
27. + T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J. Virol. 78:5707.
28. Schirmbeck, R., M. Kwissa, N. Fissolo, S. Elkholy, P. Riedl, and J. Reimann. 2002. Priming polyvalent immunity by DNA vaccines expressing chimeric antigens with a stress protein-capturing, viral J-domain. FASEB J. 16:1108.
29. + T cell responses by DNA vaccines expressing stress protein-binding polytope peptides. J. Immunol. 171:1240.
30. b mice. J. Immunol. 156:3687.
31. Zu Putlitz, J., R. E. Lanford, R. I. Carlson, L. Notvall, S. M. de la Monte, and J. R. Wands, 1999. Properties of monoclonal antibodies directed against hepatitis B virus polymerase protein. J. Virol. 73:4188.
32. Böhm, W., A. Kuhröber, T. Paier, T. Mertens, J. Reimann, and R. Schirmbeck. 1996. DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection. J. Immunol. Methods 193:29.
33. Prange, R., R. Nagel, and R. E. Streeck. 1992. Deletions in the hepatitis B virus small envelope protein: effect on assembly and secretion of surface antigen particles. J. Virol. 66:5832.
34. bm mutants. J. Virol. 64:1192.